MedTrace Logo

Combination Therapy With Two Biologicals

NCT05135221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2021-11-26

No results posted yet for this study

Summary

The efficacy and safety of dual biological therapy.

Conditions

Interventions

BIOLOGICAL

dual biological therapy

Simultaneous use of two biologicals.

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Heli Eronen · Kanta-Häme Central Hospital

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-12-30
Completion
2021-10-01

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05135221 on ClinicalTrials.gov